Tower Research Capital (TRC)’s Lux Health Tech Acquisition Corp. Class A Common Stock LUXA Stock Holding History

Tower Research Capital (TRC)’s Portfolio LUXA Stock Details LUXA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-42	Closed	–	–	6882
2022 Q3	$0	Buy	42 +22	+110%	+$219	﹤0.01%	6872
2022 Q2	$0	Sell	20 -180	-90%	-$1.78K	﹤0.01%	6954
2022 Q1	$2K	Sell	200 -588	-75%	-$5.78K	﹤0.01%	5715
2021 Q4	$8K	Buy	788 +783	+15,660%	+$7.71K	﹤0.01%	4870
2021 Q3	$0	Sell	5 -489	-99%	-$4.82K	﹤0.01%	6457
2021 Q2	$5K	Buy	+494	New	+$4.97K	﹤0.01%	4771

Tower Research Capital (TRC)'s LUXA Position: Q4 2022 in Review

Tower Research Capital (TRC) sold out of Lux Health Tech Acquisition Corp. Class A Common Stock (LUXA) in Q4 2022, closing a stake of 42 shares.

Tower Research Capital (TRC) first reported a position in LUXA in Q2 2021 and held it in 6 quarters. The position peaked at $8K in Q4 2021. 0 funds tracked by Wall St. Rank hold LUXA as of Q4 2022.

Tower Research Capital (TRC) reported no remaining Lux Health Tech Acquisition Corp. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Tower Research Capital (TRC) sold 42 Lux Health Tech Acquisition Corp. Class A Common Stock shares in Q4 2022.
Tower Research Capital (TRC) first reported a position in Lux Health Tech Acquisition Corp. Class A Common Stock in Q2 2021 and held it in 6 quarters.
Tower Research Capital (TRC)'s Lux Health Tech Acquisition Corp. Class A Common Stock position peaked at $8K in Q4 2021.
0 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Class A Common Stock as of Q4 2022.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2022, filed 10 Feb 2023.